Prosecution Insights
Last updated: May 29, 2026

Examiner: CLOW, LORI A

Tech Center 3700 • Art Units: 1631 1671 1687 3781

This examiner grants 64% of resolved cases

Performance Statistics

63.9%
Allow Rate
-6.1% vs TC avg
736
Total Applications
+28.7%
Interview Lift
1543
Avg Prosecution Days
Based on 707 resolved cases, 2023–2026

Rejection Statute Breakdown

13.2%
§101 Eligibility
12.8%
§102 Novelty
48.0%
§103 Obviousness
9.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19342186 MODEL-IN-THE-LOOP SYNTHETIC BIOLOGY Final Rejection X Development LLC
17691815 NON-INVASIVE DETERMINATION OF TISSUE SOURCE OF CELL-FREE DNA Non-Final OA The Chinese University of Hong Kong
17761628 METHODS AND SYSTEMS FOR MODELING A CARDIAC SYSTEM Non-Final OA KONINKLIJKE PHILIPS N.V.
16980141 DETERMINING ERRONEOUS CODES IN MEDICAL REPORTS Non-Final OA KONINKLIJKE PHILIPS N.V.
17817631 BIOLOGICAL SEQUENCE DISTANCE EXPLORER SYSTEM PROVIDING USER VISUALIZATION OF GENOMIC DISTANCE BETWEEN A SET OF GENOMES IN A DYNAMIC ZOOMABLE FASHION Non-Final OA International Business Machines Corporation
17623818 MULTIPLE BONE DENSITY DISPLAYING METHOD FOR ESTABLISHING IMPLANT PROCEDURE PLAN, AND IMAGE PROCESSING DEVICE THEREFOR Non-Final OA Osstem Implant Co., Ltd.
17655746 SYSTEMS AND METHODS FOR PROCESSING IMAGES TO DETERMINE PLAQUE PROGRESSION AND REGRESSION Non-Final OA HeartFlow, Inc.
17399704 SYSTEMS AND METHODS FOR PATIENT-SPECIFIC IMAGING AND MODELING OF DRUG DELIVERY Non-Final OA HeartFlow, Inc.
17691999 METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID Non-Final OA SEQUENOM, INC.
17610863 SYSTEMS AND METHODS FOR PHENOTYPING Non-Final OA Technion Research and Development Foundation Limited
17855010 METHOD AND SYSTEM FOR CONVERTING PHYSIOLOGICAL SIGNALS Final Rejection Terra Quantum AG
17543169 Method of Determining Disease Causality of Genome Mutations Final Rejection The Hospital for Sick Children
18163106 METHODS AND SYSTEMS FOR ABNORMALITY DETECTION IN THE PATTERNS OF NUCLEIC ACIDS Non-Final OA Freenome Holdings, Inc.
17425384 NOVEL BIOMARKERS AND DIAGNOSTIC PROFILES FOR PROSTATE CANCER Non-Final OA UEA ENTERPRISES LIMITED
17110101 MACHINE LEARNING USING SIMULATED CARDIOGRAMS Final Rejection Vektor Medical, Inc.
17745820 Predicting Response to Stimulus Non-Final OA Optios, Inc.
17663427 METHOD AND SYSTEM FOR DETERMINING A RISK OF HEMODYNAMIC COMPROMISE AFTER CARDIAC INTERVENTION Non-Final OA FEops NV
17581809 SYSTEM AND METHOD OF CALIBRATING CEREBRAL SENSOR ORIENTATION AND GENERATING FEEDBACK FROM CEREBRAL SENSOR INJECTOR Non-Final OA Neurasignal, Inc.
17596710 METHOD AND SYSTEM FOR DATING BLOOD POOLS Final Rejection ETAT FRANCAIS REPRESENTE PAR LE MINISTERE DE L'INTERIEUR
17268340 BIOLOGICAL COMPUTING SYSTEMS AND METHODS FOR MULTIVARIATE SURFACE ANALYSIS AND OBJECT DETECTION Non-Final OA XENO CELL INNOVATIONS S.R.O.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month